Insulet Stock Performance

PODD Stock  USD 261.63  6.19  2.42%   
Insulet has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.64, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Insulet's returns are expected to increase less than the market. However, during the bear market, the loss of holding Insulet is expected to be smaller as well. Insulet right now retains a risk of 1.98%. Please check out Insulet daily balance of power, and the relationship between the skewness and day typical price , to decide if Insulet will be following its current trending patterns.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Insulet are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Insulet is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more

Actual Historical Performance (%)

One Day Return
2.42
Five Day Return
4.54
Year To Date Return
1.86
Ten Year Return
652.03
All Time Return
1.5 K
1
Disposition of 4362 shares by Eric Benjamin of Insulet at 267.6 subject to Rule 16b-3
12/16/2024
2
Disposition of 3371 shares by Eric Benjamin of Insulet at 74.5 subject to Rule 16b-3
01/21/2025
3
Why Insulet Corporation Looks Like A Quality Company
02/06/2025
4
Insulet Corp Q4 Earnings EPS of 1. ...
02/20/2025
5
Insulet targets 16-20 percent U.S. Omnipod growth for 2025 with expanded type 2 diabetes market reach
02/21/2025
6
Disposition of 644 shares by Eric Benjamin of Insulet at 267.09 subject to Rule 16b-3
02/27/2025
7
Disposition of 492 shares by Eric Benjamin of Insulet at 272.27 subject to Rule 16b-3
02/28/2025
8
Disposition of 1875 shares by Eric Benjamin of Insulet at 74.5 subject to Rule 16b-3
03/03/2025
9
Abbott Laboratories Partners With Cadrenal Therapeutics For TECH-LVAD Trial In Growing US2B LVAD Market
03/04/2025
10
Calculating The Intrinsic Value Of Insulet Corporation
03/05/2025
11
Insulet Corp Trading Down 4.02 percent on Mar 7
03/07/2025
12
U.S. stock market crash Make sure you buy some of these quality stocks
03/11/2025
13
Insulet Co. Shares Purchased by Daiwa Securities Group Inc.
03/13/2025
Begin Period Cash Flow704.2 M
  

Insulet Relative Risk vs. Return Landscape

If you would invest  25,644  in Insulet on December 18, 2024 and sell it today you would earn a total of  519.00  from holding Insulet or generate 2.02% return on investment over 90 days. Insulet is currently generating 0.0534% in daily expected returns and assumes 1.9824% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Insulet, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Insulet is expected to generate 2.32 times more return on investment than the market. However, the company is 2.32 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.02 per unit of risk.

Insulet Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Insulet's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insulet, and traders can use it to determine the average amount a Insulet's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.027

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskPODDHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.98
  actual daily
17
83% of assets are more volatile

Expected Return

 0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average Insulet is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insulet by adding it to a well-diversified portfolio.

Insulet Fundamentals Growth

Insulet Stock prices reflect investors' perceptions of the future prospects and financial health of Insulet, and Insulet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insulet Stock performance.

About Insulet Performance

By analyzing Insulet's fundamental ratios, stakeholders can gain valuable insights into Insulet's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Insulet has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Insulet has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 250.99  263.54 
Return On Tangible Assets 0.14  0.15 
Return On Capital Employed 0.12  0.13 
Return On Assets 0.14  0.14 
Return On Equity 0.35  0.36 

Things to note about Insulet performance evaluation

Checking the ongoing alerts about Insulet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insulet help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Insulet is unlikely to experience financial distress in the next 2 years
Over 100.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Insulet Co. Shares Purchased by Daiwa Securities Group Inc.
Evaluating Insulet's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Insulet's stock performance include:
  • Analyzing Insulet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insulet's stock is overvalued or undervalued compared to its peers.
  • Examining Insulet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Insulet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insulet's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Insulet's stock. These opinions can provide insight into Insulet's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Insulet's stock performance is not an exact science, and many factors can impact Insulet's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Insulet Stock analysis

When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope